151 related articles for article (PubMed ID: 35942654)
21. Recently described types of dysplasia associated with IBD: tips and clues for the practising pathologist.
Alipour Z; Stashek K
J Clin Pathol; 2024 Jan; 77(2):77-81. PubMed ID: 37918911
[TBL] [Abstract][Full Text] [Related]
22. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
[TBL] [Abstract][Full Text] [Related]
23. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?
Broomé U; Lindberg G; Löfberg R
Gastroenterology; 1992 Jun; 102(6):1877-80. PubMed ID: 1587406
[TBL] [Abstract][Full Text] [Related]
24. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Rutter M; Saunders B; Wilkinson K; Rumbles S; Schofield G; Kamm M; Williams C; Price A; Talbot I; Forbes A
Gastroenterology; 2004 Feb; 126(2):451-9. PubMed ID: 14762782
[TBL] [Abstract][Full Text] [Related]
25. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
26. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
Choi WT; Rabinovitch PS; Wang D; Westerhoff M
Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
[TBL] [Abstract][Full Text] [Related]
27. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
28. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
[TBL] [Abstract][Full Text] [Related]
29. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
Mahmoud R; Shah SC; Ten Hove JR; Torres J; Mooiweer E; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH;
Gastroenterology; 2019 Apr; 156(5):1333-1344.e3. PubMed ID: 30529584
[TBL] [Abstract][Full Text] [Related]
30. Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis.
Sasson AN; Sheehan G; Yu A; Gupta A; Ling K; Kochar B; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1353-e1364. PubMed ID: 34425278
[TBL] [Abstract][Full Text] [Related]
31. Validated Indices for Histopathologic Activity Predict Development of Colorectal Neoplasia in Ulcerative Colitis.
Pai RK; Hartman DJ; Leighton JA; Pasha SF; Rivers CR; Regueiro M; Binion DG; Pai RK
J Crohns Colitis; 2021 Sep; 15(9):1481-1490. PubMed ID: 33687061
[TBL] [Abstract][Full Text] [Related]
32. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
[TBL] [Abstract][Full Text] [Related]
33. Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.
Choi CR; Al Bakir I; Ding NJ; Lee GH; Askari A; Warusavitarne J; Moorghen M; Humphries A; Ignjatovic-Wilson A; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
Gut; 2019 Mar; 68(3):414-422. PubMed ID: 29150489
[TBL] [Abstract][Full Text] [Related]
34. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
Broomé U; Löfberg R; Veress B; Eriksson LS
Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
[TBL] [Abstract][Full Text] [Related]
35. Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis.
Klepp P; Tollisen A; Røseth A; Cvancarova Småstuen M; Andersen SN; Vatn M; Moum BA; Brackmann S
World J Gastroenterol; 2018 Sep; 24(35):4069-4076. PubMed ID: 30254411
[TBL] [Abstract][Full Text] [Related]
36. Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
Hu AB; Burke KE; Kochar B; Ananthakrishnan AN
Inflamm Bowel Dis; 2021 May; 27(6):779-786. PubMed ID: 32812048
[TBL] [Abstract][Full Text] [Related]
37. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
Aitola P; Mattila J; Matikainen M
Int J Colorectal Dis; 2000 Jun; 15(3):167-71. PubMed ID: 10954188
[TBL] [Abstract][Full Text] [Related]
38. Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
Vleugels JLA; Rutter MD; Ragunath K; Rees CJ; Ponsioen CY; Lahiff C; Ket SN; Wanders LK; Samuel S; Butt F; Kuiper T; Travis SPL; D'Haens G; Wang LM; van Eeden S; East JE; Dekker E
Lancet Gastroenterol Hepatol; 2018 May; 3(5):305-316. PubMed ID: 29567006
[TBL] [Abstract][Full Text] [Related]
39. The Fate of Unifocal Versus Multifocal Low-Grade Dysplasia at the Time of Colonoscopy in Patients With IBD.
Lightner AL; Vogler SA; Vaidya PS; McMichael JP; Jia X; Regueiro M; Steele SR
Dis Colon Rectum; 2021 Nov; 64(11):1364-1373. PubMed ID: 34623348
[TBL] [Abstract][Full Text] [Related]
40. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
